<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.jnanobiotechnology.com/feeds/latestarticles/journal?quantity=&amp;format=rss&amp;version=">
        <title>Journal of Nanobiotechnology - Latest Articles</title>
        <link>http://www.jnanobiotechnology.com</link>
        <description>The latest research articles published by Journal of Nanobiotechnology</description>
        <dc:date>2013-05-03T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.jnanobiotechnology.com/content/11/1/14" />
                                <rdf:li rdf:resource="http://www.jnanobiotechnology.com/content/11/1/13" />
                                <rdf:li rdf:resource="http://www.jnanobiotechnology.com/content/11/1/12" />
                                <rdf:li rdf:resource="http://www.jnanobiotechnology.com/content/11/1/11" />
                                <rdf:li rdf:resource="http://www.jnanobiotechnology.com/content/11/1/10" />
                                <rdf:li rdf:resource="http://www.jnanobiotechnology.com/content/11/1/9" />
                                <rdf:li rdf:resource="http://www.jnanobiotechnology.com/content/11/1/8" />
                                <rdf:li rdf:resource="http://www.jnanobiotechnology.com/content/11/1/7" />
                                <rdf:li rdf:resource="http://www.jnanobiotechnology.com/content/11/1/6" />
                                <rdf:li rdf:resource="http://www.jnanobiotechnology.com/content/11/1/5" />
                            </rdf:Seq>
        </items>
                 <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.jnanobiotechnology.com/content/11/1/14">
        <title>Magnetic capture from blood rescues molecular motor function in diagnostic nanodevices</title>
        <description>Background:
Introduction of effective point-of-care devices for use in medical diagnostics is part of strategies to combat accelerating health-care costs. Molecular motor driven nanodevices have unique potentials in this regard due to unprecedented level of miniaturization and independence of external pumps. However motor function has been found to be inhibited by body fluids.
Results:
We report here that a unique procedure, combining separation steps that rely on antibody-antigen interactions, magnetic forces applied to magnetic nanoparticles (MPs) and the specificity of the actomyosin bond, can circumvent the deleterious effects of body fluids (e.g. blood serum). The procedure encompasses the following steps: (i) capture of analyte molecules from serum by MP-antibody conjugates, (ii) pelleting of MP-antibody-analyte complexes, using a magnetic field, followed by exchange of serum for optimized biological buffer, (iii) mixing of MP-antibody-analyte complexes with actin filaments conjugated with same polyclonal antibodies as the magnetic nanoparticles. This causes complex formation: MP-antibody-analyte-antibody-actin, and magnetic separation is used to enrich the complexes. Finally (iv) the complexes are introduced into a nanodevice for specific binding via actin filaments to surface adsorbed molecular motors (heavy meromyosin). The number of actin filaments bound to the motors in the latter step was significantly increased above the control value if protein analyte (50&#8211;60 nM) was present in serum (in step i) suggesting appreciable formation and enrichment of the MP-antibody-analyte-antibody-actin complexes. Furthermore, addition of ATP demonstrated maintained heavy meromyosin driven propulsion of actin filaments showing that the serum induced inhibition was alleviated. Detailed analysis of the procedure i-iv, using fluorescence microscopy and spectroscopy identified main targets for future optimization.
Conclusion:
The results demonstrate a promising approach for capturing analytes from serum for subsequent motor driven separation/detection. Indeed, the observed increase in actin filament number, in itself, signals the presence of analyte at clinically relevant nM concentration without the need for further motor driven concentration. Our analysis suggests that exchange of polyclonal for monoclonal antibodies would be a critical improvement, opening for a first clinically useful molecular motor driven lab-on-a-chip device.</description>
        <link>http://www.jnanobiotechnology.com/content/11/1/14</link>
                <dc:creator>Saroj Kumar</dc:creator>
                <dc:creator>Lasse ten Siethoff</dc:creator>
                <dc:creator>Malin Persson</dc:creator>
                <dc:creator>Nuria Albet-Torres</dc:creator>
                <dc:creator>Alf Månsson</dc:creator>
                <dc:source>Journal of Nanobiotechnology 2013, null:14</dc:source>
        <dc:date>2013-05-03T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-3155-11-14</dc:identifier>
                                <prism:require>/content/figures/1477-3155-11-14-toc.gif</prism:require>
                <prism:publicationName>Journal of Nanobiotechnology</prism:publicationName>
        <prism:issn>1477-3155</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>14</prism:startingPage>
        <prism:publicationDate>2013-05-03T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnanobiotechnology.com/content/11/1/13">
        <title>Enhanced biocidal activity of Au nanoparticles synthesized in one pot using 2, 4-dihydroxybenzene carbodithioic acid as a reducing and stabilizing agent</title>
        <description>Background:
The conjugation of gold nanoparticles with biocides such as natural products, oligosaccharides, DNA, proteins has attracted great attention of scientists recently. Gold NPs covered with biologically important molecules showed significant enhancement in biological activity in comparison with the activity of the free biocides. However, these reports are not very systematic and do not allow to draw definitive conclusions. We therefore embarked in a systematic study related to the synthesis and characterization of biocidal activities of Au nanoparticles conjugated to a wide variety of synthetic and natural biomolecules. In this specific report, we investigated the activity of a synthetic biocide, 2-4, Dihydroxybenzene carbodithioic acid (DHT).
Results:
Au nanoparticles (NP) with a mean size of about 20 nm were synthesized and functionalized in one pot with the help of biocide 2,4-Dihydroxybenzene carbodithioic acid (DHT) to reduce HAuCl4 in aqueous solution. Conjugation of DHT with gold was confirmed by FT-IR and the amount of DHT conjugated to the Au nanoparticles was found to be 7% by weight by measuring the concentration of DHT in the supernatant after centrifugation of the Au NPs. To ascertain the potential for in vivo applications, the stability of the suspensions was investigated as a function of pH, temperature and salt concentration. Antibacterial, antifungal, insecticidal and cytotoxic activities of the Au-DHT conjugates were compared with those of pure DHT and of commercially available biocides. In all cases, the biocidal activity of the Au-DHT conjugates was comparable to that of commercial products and of DHT.
Conclusions:
Since the DHT concentration in the Au-DHT conjugates was only about 7%, our results indicate that conjugation to the Au NPs boosts the biocidal activity of DHT by about 14 times. The suspensions were found to be stable for several days at temperatures of up to 100 0C, salt concentrations up to 4 mol/L and a pH range of 2-13.</description>
        <link>http://www.jnanobiotechnology.com/content/11/1/13</link>
                <dc:creator>Syeda Naz</dc:creator>
                <dc:creator>Nazar Islam</dc:creator>
                <dc:creator>Muhammad Shah</dc:creator>
                <dc:creator>Syed Alam</dc:creator>
                <dc:creator>Zafar Iqbal</dc:creator>
                <dc:creator>Massimo Bertino</dc:creator>
                <dc:creator>Louis Franzel</dc:creator>
                <dc:creator>Afifa Ahmed</dc:creator>
                <dc:source>Journal of Nanobiotechnology 2013, null:13</dc:source>
        <dc:date>2013-04-22T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-3155-11-13</dc:identifier>
                                <prism:require>/content/figures/1477-3155-11-13-toc.gif</prism:require>
                <prism:publicationName>Journal of Nanobiotechnology</prism:publicationName>
        <prism:issn>1477-3155</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>13</prism:startingPage>
        <prism:publicationDate>2013-04-22T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnanobiotechnology.com/content/11/1/12">
        <title>Electron beam fabrication of a microfluidic device for studying submicron-scale bacteria</title>
        <description>Background:
Controlled restriction of cellular movement using microfluidics allows one to study individual cells to gain insight into aspects of their physiology and behaviour. For example, the use of micron-sized growth channels that confine individual Escherichia coli has yielded novel insights into cell growth and death. To extend this approach to other species of bacteria, many of whom have dimensions in the sub-micron range, or to a larger range of growth conditions, a readily-fabricated device containing sub-micron features is required.
Results:
Here we detail the fabrication of a versatile device with growth channels whose widths range from 0.3 &#956;m to 0.8 &#956;m. The device is fabricated using electron beam lithography, which provides excellent control over the shape and size of different growth channels and facilitates the rapid-prototyping of new designs. Features are successfully transferred first into silicon, and subsequently into the polydimethylsiloxane that forms the basis of the working microfluidic device. We demonstrate that the growth of sub-micron scale bacteria such as Lactococcus lactis or Escherichia coli cultured in minimal medium can be followed in such a device over several generations.
Conclusions:
We have presented a detailed protocol based on electron beam fabrication together with specific dry etching procedures for the fabrication of a microfluidic device suited to study submicron-sized bacteria. We have demonstrated that both Gram-positive and Gram-negative bacteria can be successfully loaded and imaged over a number of generations in this device. Similar devices could potentially be used to study other submicron-sized organisms under conditions in which the height and shape of the growth channels are crucial to the experimental design.</description>
        <link>http://www.jnanobiotechnology.com/content/11/1/12</link>
                <dc:creator>Martinus Moolman</dc:creator>
                <dc:creator>Zhuangxiong Huang</dc:creator>
                <dc:creator>Sriram Krishnan</dc:creator>
                <dc:creator>Jacob Kerssemakers</dc:creator>
                <dc:creator>Nynke Dekker</dc:creator>
                <dc:source>Journal of Nanobiotechnology 2013, null:12</dc:source>
        <dc:date>2013-04-10T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-3155-11-12</dc:identifier>
                                <prism:require>/content/figures/1477-3155-11-12-toc.gif</prism:require>
                <prism:publicationName>Journal of Nanobiotechnology</prism:publicationName>
        <prism:issn>1477-3155</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>12</prism:startingPage>
        <prism:publicationDate>2013-04-10T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnanobiotechnology.com/content/11/1/11">
        <title>Microtechnologies to fuel neurobiological research with nanometer precision</title>
        <description>The interface between engineering and molecular life sciences has been fertile ground for advancing our understanding of complex biological systems. Engineered microstructures offer a diverse toolbox for cellular and molecular biologists to direct the placement of cells and small organisms, and to recreate biological functions in vitro: cells can be positioned and connected in a designed fashion, and connectivity and community effects of cells studied. Because of the highly polar morphology and finely compartmentalized functions of neurons, microfabricated cell culture systems and related on-chip technologies have become an important enabling platform for studying development, function and degeneration of the nervous system at the molecular and cellular level. Here we review some of the compartmentalization techniques developed so far to highlight how high-precision control of neuronal connectivity allows new approaches for studying axonal and synaptic biology.</description>
        <link>http://www.jnanobiotechnology.com/content/11/1/11</link>
                <dc:creator>Cecilia Brunello</dc:creator>
                <dc:creator>Ville Jokinen</dc:creator>
                <dc:creator>Prasanna Sakha</dc:creator>
                <dc:creator>Hideyuki Terazono</dc:creator>
                <dc:creator>Fumimasa Nomura</dc:creator>
                <dc:creator>Tomoyuki Kaneko</dc:creator>
                <dc:creator>Sari Lauri</dc:creator>
                <dc:creator>Sami Franssila</dc:creator>
                <dc:creator>Claudio Rivera</dc:creator>
                <dc:creator>Kenji Yasuda</dc:creator>
                <dc:creator>Henri Huttunen</dc:creator>
                <dc:source>Journal of Nanobiotechnology 2013, null:11</dc:source>
        <dc:date>2013-04-10T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-3155-11-11</dc:identifier>
                                <prism:require>/content/figures/1477-3155-11-11-toc.gif</prism:require>
                <prism:publicationName>Journal of Nanobiotechnology</prism:publicationName>
        <prism:issn>1477-3155</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>11</prism:startingPage>
        <prism:publicationDate>2013-04-10T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnanobiotechnology.com/content/11/1/10">
        <title>Engineering of papaya mosaic virus (PapMV) nanoparticles with a CTL epitope derived from influenza NP</title>
        <description>Background:
The ever-present threat of infectious disease, e.g. influenza pandemics, and the increasing need for new and effective treatments in immunotherapy are the driving forces that motivate research into new and innovative vaccine platforms. Ideally, such platforms should trigger an efficient CTL response, be safe, and easy to manufacture. We recently developed a novel nanoparticle adjuvant comprised of papaya mosaic virus (PapMV) coat protein (CP) assembled around an RNA. The PapMV nanoparticle is an efficient vaccine platform in which the peptide antigen is fused to the C-terminus of the PapMV CP, leading to nanoparticles presenting surface-exposed epitope. The fusion stabilizes the epitope and improves its immunogenicity. We found recently that C-terminal fusions are not always efficient, depending on the nature of the peptide fused to the platform.
Results:
We chose a CTL epitope derived from the nucleocapsid (NP) of influenza virus (NP147-155) for this proof-of-concept demonstration. Recombinant nanoparticles harbouring a fusion at the N-terminus were more efficient in triggering a CTL response. Efficacy appeared to be linked to the stability of the nanoparticles at 37&#176;C. We also showed that discs&#8212;smaller than nanoparticles&#8212;made of 20 subunits of PapMV CP are less efficient for induction of a CTL response in mice, revealing that assembly of the recombinant PapMV CP into nanoparticles is crucial to triggering an efficient CTL response.
Conclusion:
The point of fusion on the PapMV vaccine platform is critical to triggering an efficient CTL response. Efficacy is linked to nanoparticle stability; nanoparticles must be stable at 37&#176;C but remain susceptible to cellular proteases to ensure efficient processing of the CTL epitope by cells of the immune system. The results of this study improve our understanding of the PapMV vaccine platform, which will facilitate the design of efficient vaccines to various infectious threats.</description>
        <link>http://www.jnanobiotechnology.com/content/11/1/10</link>
                <dc:creator>Cindy Babin</dc:creator>
                <dc:creator>Nathalie Majeau</dc:creator>
                <dc:creator>Denis Leclerc</dc:creator>
                <dc:source>Journal of Nanobiotechnology 2013, null:10</dc:source>
        <dc:date>2013-04-04T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-3155-11-10</dc:identifier>
                                <prism:require>/content/figures/1477-3155-11-10-toc.gif</prism:require>
                <prism:publicationName>Journal of Nanobiotechnology</prism:publicationName>
        <prism:issn>1477-3155</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>10</prism:startingPage>
        <prism:publicationDate>2013-04-04T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnanobiotechnology.com/content/11/1/9">
        <title>Polyamidoamine dendrimer impairs mitochondrial oxidation in brain tissue</title>
        <description>Background:
The potential nanocarrier polyamidoamine (PAMAM) generation 5 (G5-NH2) dendrimer has been shown to evoke lasting neuronal depolarization and cell death in a concentration-dependent manner. In this study we explored the early progression of G5-NH2 action in brain tissue on neuronal and astroglial cells.
Results:
In order to describe early mechanisms of G5-NH2 dendrimer action in brain tissue we assessed G5-NH2 trafficking, free intracellular Ca2+ and mitochondrial membrane potential (&#936;MITO) changes in the rat hippocampal slice by microfluorimetry. With the help of fluorescent dye conjugated G5-NH2, we observed predominant appearance of the dendrimer in the plasma membrane of pyramidal neurons and glial cells within 30 min. Under this condition, G5-NH2 evoked robust intracellular Ca2+ enhancements and &#936;MITO depolarization both in pyramidal neurons and astroglial cells. Intracellular Ca2+ enhancements clearly preceded &#936;MITO depolarization in astroglial cells. Comparing activation dynamics, neurons and glia showed prevalence of lasting and transient &#936;MITO depolarization, respectively. Transient as opposed to lasting &#936;MITO changes to short-term G5-NH2 application suggested better survival of astroglia, as observed in the CA3 stratum radiatum area. We also showed that direct effect of G5-NH2 on astroglial &#936;MITO was significantly enhanced by neuron-astroglia interaction, subsequent to G5-NH2 evoked neuronal activation.
Conclusion:
These findings indicate that the interaction of the PAMAM dendrimer with the plasma membrane leads to robust activation of neurons and astroglial cells, leading to mitochondrial depolarization. Distinguishable dynamics of mitochondrial depolarization in neurons and astroglia suggest that the enhanced mitochondrial depolarization followed by impaired oxidative metabolism of neurons may be the primary basis of neurotoxicity.</description>
        <link>http://www.jnanobiotechnology.com/content/11/1/9</link>
                <dc:creator>Gabriella Nyitrai</dc:creator>
                <dc:creator>László Héja</dc:creator>
                <dc:creator>István Jablonkai</dc:creator>
                <dc:creator>Ildikó Pál</dc:creator>
                <dc:creator>Júlia Visy</dc:creator>
                <dc:creator>Julianna Kardos</dc:creator>
                <dc:source>Journal of Nanobiotechnology 2013, null:9</dc:source>
        <dc:date>2013-04-04T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-3155-11-9</dc:identifier>
                                <prism:require>/content/figures/1477-3155-11-9-toc.gif</prism:require>
                <prism:publicationName>Journal of Nanobiotechnology</prism:publicationName>
        <prism:issn>1477-3155</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>9</prism:startingPage>
        <prism:publicationDate>2013-04-04T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnanobiotechnology.com/content/11/1/8">
        <title>Analysis of RNA base modification and structural rearrangement by single-molecule real-time detection of reverse transcription</title>
        <description>Background:
Zero-mode waveguides (ZMWs) are photonic nanostructures that create highly confined optical observation volumes, thereby allowing single-molecule-resolved biophysical studies at relatively high concentrations of fluorescent molecules. This principle has been successfully applied in single-molecule, real-time (SMRT&#174;) DNA sequencing for the detection of DNA sequences and DNA base modifications. In contrast, RNA sequencing methods cannot provide sequence and RNA base modifications concurrently as they rely on complementary DNA (cDNA) synthesis by reverse transcription followed by sequencing of cDNA. Thus, information on RNA modifications is lost during the process of cDNA synthesis.
Results:
Here we describe an application of SMRT technology to follow the activity of reverse transcriptase enzymes synthesizing cDNA on thousands of single RNA templates simultaneously in real time with single nucleotide turnover resolution using arrays of ZMWs. This method thereby obtains information from the RNA template directly. The analysis of the kinetics of the reverse transcriptase can be used to identify RNA base modifications, shown by example for N6-methyladenine (m6A) in oligonucleotides and in a specific mRNA extracted from total cellular mRNA. Furthermore, the real-time reverse transcriptase dynamics informs about RNA secondary structure and its rearrangements, as demonstrated on a ribosomal RNA and an mRNA template.
Conclusions:
Our results highlight the feasibility of studying RNA modifications and RNA structural rearrangements in ZMWs in real time. In addition, they suggest that technology can be developed for direct RNA sequencing provided that the reverse transcriptase is optimized to resolve homonucleotide stretches in RNA.</description>
        <link>http://www.jnanobiotechnology.com/content/11/1/8</link>
                <dc:creator>Igor Vilfan</dc:creator>
                <dc:creator>Yu-Chih Tsai</dc:creator>
                <dc:creator>Tyson Clark</dc:creator>
                <dc:creator>Jeffrey Wegener</dc:creator>
                <dc:creator>Qing Dai</dc:creator>
                <dc:creator>Chengqi Yi</dc:creator>
                <dc:creator>Tao Pan</dc:creator>
                <dc:creator>Stephen Turner</dc:creator>
                <dc:creator>Jonas Korlach</dc:creator>
                <dc:source>Journal of Nanobiotechnology 2013, null:8</dc:source>
        <dc:date>2013-04-03T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-3155-11-8</dc:identifier>
                                <prism:require>/content/figures/1477-3155-11-8-toc.gif</prism:require>
                <prism:publicationName>Journal of Nanobiotechnology</prism:publicationName>
        <prism:issn>1477-3155</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>8</prism:startingPage>
        <prism:publicationDate>2013-04-03T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnanobiotechnology.com/content/11/1/7">
        <title>Chemistry of conjugation to gold nanoparticles affects G-protein activity differently</title>
        <description>Background:
Gold nanoparticles (AuNP) are extensively used as biophysical tools in the area of medicine and technology due to their distinct properties. However, vivid understanding of the consequences of biomolecule-nanomaterial interactions is still lacking. In this context, we explore the affect of conjugation of G&#945;i1 subunit (of heterotrimeric G-proteins) to AuNP and examine its consequences. We consider two bio-conjugation strategies covalent and non-covalent binding.
Results:
Affinity of the AuNP to the G&#945;i1 is 7.58&#8201;&#215;&#8201;10 12&#8201;M-1. AuNP conjugated G&#945;i1 exhibits altered kinetics of activation, non-covalent bio-conjugates displays retarded kinetics, up to 0.88 fold when GTP&#947;S was used as ligand, of protein activation contrary to covalent conjugates which accelerates it to&#8201;~&#8201;5 fold. Conjugation influence intrinsic G&#945;i1 GTPase function in conflicting modes. Non-covalent conjugation inhibits GTPase function (decrease in activity upto 0.8 fold) whilst covalent conjugation drastically accelerates it (12 fold increase in activity). Altered basal nucleotide uptake in both types of conjugates and GTPase function in non-covalent conjugate are almost comparable except for GTPase property of covalent conjugate. The effect is despite the fact that conjugation does not change global conformation of the protein.
Conclusion:
These findings provide clear evidence that nanoparticles, in addition to &#8216;passive interaction&#8217; with protein (biomolecule), can interact &#8220;actively&#8221; with biomolecule and modify its function. This concept should be considered while engineering nanoparticle based delivery systems in medicine.</description>
        <link>http://www.jnanobiotechnology.com/content/11/1/7</link>
                <dc:creator>Vibha Singh</dc:creator>
                <dc:creator>Santhosh P Nagappan Nair</dc:creator>
                <dc:creator>Gopala Krishna Aradhyam</dc:creator>
                <dc:source>Journal of Nanobiotechnology 2013, null:7</dc:source>
        <dc:date>2013-03-19T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-3155-11-7</dc:identifier>
                                <prism:require>/content/figures/1477-3155-11-7-toc.gif</prism:require>
                <prism:publicationName>Journal of Nanobiotechnology</prism:publicationName>
        <prism:issn>1477-3155</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>7</prism:startingPage>
        <prism:publicationDate>2013-03-19T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnanobiotechnology.com/content/11/1/6">
        <title>Supramolecular glucose oxidase-SWNT conjugates formed by ultrasonication: effect of tube length, functionalization and processing time</title>
        <description>Background:
Generation-3 (Gen-3) biosensors and advanced enzyme biofuel cells will benefit from direct electron transfer to oxidoreductases facilitated by single-walled carbon nanotubes (SWNTs).
Methods:
Supramolecular conjugates of SWNT-glucose oxidase (GOx-SWNT) were produced via ultrasonic processing. Using a Plackett-Burman experimental design to investigate the process of tip ultrasonication (23&#8201;kHz), conjugate formation was investigated as a function of ultrasonication times (0, 5, 60&#8201;min) and functionalized SWNTs of various tube lengths (SWNT-X-L), (X&#8201;=&#8201;&#8722;OH or -COOH and L&#8201;=&#8201;3.0&#8201;&#956;m, 7.5&#8201;&#956;m).
Results:
Enzyme activity (KM, k
						cat, k
						cat/KM, vmax and n (the Hill parameter)) of pGOx (pristine), sGOx (sonicated) and GOx-SWNT-X-L revealed that sonication of any duration increased both KM and k
						cat of GOx but did not change k
						cat/KM. Functionalized tubes had the most dramatic effect, reducing both KM and k
						cat and reducing k
						cat/KM. UV&#8211;vis spectra over the range of 300 to 550&#8201;nm of native enzyme-bound FAD (&#955;max at 381 and 452&#8201;nm) or the blue-shifted solvated FAD of the denatured enzyme (&#955;max at 377 and 448&#8201;nm) revealed that ultrasonication up to 60&#8201;minutes had no influence on spectral characteristics of FAD but that the longer SWNTs caused some partial denaturation leading to egress of FAD. Circular dichroism spectral analysis of the 2&#176; structure showed that sonication of any duration caused enrichment in the &#945;-helical content at the sacrifice of the unordered sequences in GOx while the presence of SWNTs, regardless of length and/or functionality, reduced the &#946;-sheet content of pristine GOx. Surface profiling by white light interferometry revealed that ultrasonication produced some aggregation of GOx and that GOx effectively debundled the SWNT.
Conclusions:
Supramolecular conjugates formed from shorter, -OH functionalized SWNTs using longer sonication times (60&#8201;min) gave the most favored combination for forming bioactive conjugates.</description>
        <link>http://www.jnanobiotechnology.com/content/11/1/6</link>
                <dc:creator>Olukayode Karunwi</dc:creator>
                <dc:creator>Anthony Guiseppi-Elie</dc:creator>
                <dc:source>Journal of Nanobiotechnology 2013, null:6</dc:source>
        <dc:date>2013-02-20T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-3155-11-6</dc:identifier>
                                <prism:require>/content/figures/1477-3155-11-6-toc.gif</prism:require>
                <prism:publicationName>Journal of Nanobiotechnology</prism:publicationName>
        <prism:issn>1477-3155</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>6</prism:startingPage>
        <prism:publicationDate>2013-02-20T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnanobiotechnology.com/content/11/1/5">
        <title>Silver nanoparticles of Albizia adianthifolia: the induction of apoptosis in human lung carcinoma cell line</title>
        <description>Background:
Silver nanoparticles (AgNP), the most popular nano-compounds, possess unique properties. Albizia adianthifolia (AA) is a plant of the Fabaceae family that is rich in saponins. The biological properties of a novel AgNP, synthesized from an aqueous leaf extract of AA (AAAgNP), were investigated on A549 lung cells. Cell viability was determined by the MTT assay. Cellular oxidative status (lipid peroxidation and glutathione (GSH) levels), ATP concentration, caspase-3/-7, -8 and &#8722;9 activities were determined. Apoptosis, mitochondrial (mt) membrane depolarization (flow cytometry) and DNA fragmentation (comet assay) were assessed. The expression of CD95 receptors, p53, bax, PARP-1 and smac/DIABLO was evaluated by flow cytometry and/or western blotting.
Results:
Silver nanoparticles of AA caused a dose-dependent decrease in cell viability with a significant increase in lipid peroxidation (5-fold vs. control; p&#8201;=&#8201;0.0098) and decreased intracellular GSH (p&#8201;=&#8201;0.1184). A significant 2.5-fold decrease in cellular ATP was observed upon AAAgNP exposure (p&#8201;=&#8201;0.0040) with a highly significant elevation in mt depolarization (3.3-fold vs. control; p&#8201;&lt;&#8201;0.0001). Apoptosis was also significantly higher (1.5-fold) in AAAgNP treated cells (p&#8201;&lt;&#8201;0.0001) with a significant decline in expression of CD95 receptors (p&#8201;=&#8201;0.0416). Silver nanoparticles of AA caused a significant 2.5-fold reduction in caspase-8 activity (p&#8201;=&#8201;0.0024) with contrasting increases in caspase-3/-7 (1.7-fold vs. control; p&#8201;=&#8201;0.0180) and &#8722;9 activity (1.4-fold vs. control; p&#8201;=&#8201;0.0117). Western blots showed increased expression of smac/DIABLO (4.1-fold) in treated cells (p&#8201;=&#8201;0.0033). Furthermore, AAAgNP significantly increased the expression of p53, bax and PARP-1 (1.2-fold; p&#8201;=&#8201;0.0498, 1.6-fold; p&#8201;=&#8201;0.0083 and 1.1-fold; p&#8201;=&#8201;0.0359 respectively).
Conclusion:
Data suggests that AAAgNP induces cell death in the A549 lung cells via the mt mediated intrinsic apoptotic program. Further investigation is required to potentiate the use of this novel compound in cancer therapy trials.</description>
        <link>http://www.jnanobiotechnology.com/content/11/1/5</link>
                <dc:creator>Rishalan Govender</dc:creator>
                <dc:creator>Alisa Phulukdaree</dc:creator>
                <dc:creator>Robert Gengan</dc:creator>
                <dc:creator>Krishnan Anand</dc:creator>
                <dc:creator>Anil Chuturgoon</dc:creator>
                <dc:source>Journal of Nanobiotechnology 2013, null:5</dc:source>
        <dc:date>2013-02-18T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-3155-11-5</dc:identifier>
                                <prism:require>/content/figures/1477-3155-11-5-toc.gif</prism:require>
                <prism:publicationName>Journal of Nanobiotechnology</prism:publicationName>
        <prism:issn>1477-3155</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>5</prism:startingPage>
        <prism:publicationDate>2013-02-18T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
